Photo: Business Line
No 'Scientific Rationale' In Conducting Phase-3 Trials Of Sputnik: Dr Reddy's Labs
Hyderabad-based pharmaceutical company, Dr. Reddy’s Laboratories has been denied to conduct phase-3 trials of Sputnik Light Covid-19 vaccine in India. An expert committee of CDSCO has refused the company to conduct trials because it was unable to find the "scientific rationale" behind it. Last September, the company collaborated with the Russian Direct Investment Fund (RDIF)… read-more
Tags: Covid-19, Dr, Dr. Reddy's Laboratory, Sputnik V, Vaccine Trial
Courtesy: Hindustan Times
Photo: The Wire Science
DCGI Gives Emergency Use Approval To DRDO's Anti-COVID Drug
The DCGI has given an emergency use approval to the DRDO developed drug capable of curing COVID-19. The drug, in powder form to be taken orally by dissolving in water, is jointly developed by DRDO lab and Hyderabad’s Dr. Reddy's laboratory. Reportedly, using the therapeutic application of the drug 2-deoxy-D-glucose (2-DG), the novel drug showed signs of faster recovery in hospitalized patients while reducing supplemental oxygen dependency… read-more
Tags: DRDO, Dr. Reddy's Laboratory, COVID-19 DRUG, COVID-19 outbreak, anti-covid drug
Courtesy: NDTV
Photo: News Track
100Mn Sputnik V Covid Vaccines To Be Produced In India
India plans to produce over 100 million doses of Russian Covid-19 vaccine Sputnik V. As per reports, Russian Direct Investment Fund (RDIF) will help Indian pharma company Hetero in producing Sputnik V doses from early 2021. Amid ongoing lab tests of the vaccine, Dr Reddy's Laboratories expects the final trials to be over by March 2021. In addition to this, the RDIF is marketing the Sputnik V vaccine globally.
Tags: Sputnik-V, India, Russia, Covid-19, Covid-19 Vaccine, Dr. Reddy's Laboratory
Courtesy: The Times of India
